Increasing use of social media throughout early adolescence is associated with lower performance in specific aspects of cognitive function.

Introduction A substantial number of patients with major depressive disorder experience non-remission despite treatment with psychotherapy and several antidepressant drugs. This has increased the ...

Introduction The number of people living with dementia is increasing worldwide. Alzheimer’s disease (AD) is the most common type of dementia. It typically manifests itself initially with cognitive ...

Roche’s test, which measures the blood level of pTau181, a protein that builds up in the brain tissue of Alzheimer’s patients ...

The FDA has cleared Elecsys pTau181, the first blood test for use in primary care to help rule out Alzheimers disease in adults 55 and older with memory or thinking changes. A negative result strongly ...

New research shows that the brain’s ability to detect subtle visual changes—like spotting an anomaly on a security ...

Both low and high increases in use were negatively but weakly associated with adolescent cognitive performance 2 years later.

The availability of a rule-in-rule-out test for Alzheimer’s disease in primary care settings is likely to drive efficiencies throughout the care continuum.

The FDA has granted 510(k) clearance to a blood-based biomarker test indicated for early detection of Alzheimer’s disease and other causes of cognitive decline within a primary care setting, according ...

The FDA has cleared the Elecsys pTau181 test as an aid in early detection of amyloid pathology in the primary care setting for adults aged 55 years and older presenting with signs, symptoms or ...

The results of this experiment appear to indicate that the presentation of encouraging and supportive platitudes may actually ...